A next-generation support system and personalised therapy platform for individuals with neurological conditions, as well as their family/caregivers.
A next-generation support system and personalised therapy platform for individuals with neurological conditions, as well as their family/caregivers.
批准号:
10045001
负责人:
金额:
$6.31万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2022
资助国家:
英国
项目状态:
已结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rehabilitation for individuals who have suffered a brain injury, stroke, and other similar neurological conditions is stuck in a decades-long rut. Among experts, it has long been agreed that the NHS does not satisfy the demand, and the gap between acceptable and available service is worsening.Private services and sectors such as medico-legal and medical-insurance provide some relief, though at costs only affordable to those with insurance claims or an alternative funding source.Neumind was founded by engineers and identical twin brothers, one of whom suffered a life-altering brain injury. We understand the difficult journey of recovery and know how little support is out there, from limited rehabilitation to extortionate healthcare costs. Over the past two years, we have worked with hundreds of individuals, families and clinicians to design the most complete and affordable system to support people post-discharge.We combine technology, best clinical practice and a deep understanding of the people we serve to help them live more independent, fulfilling and happy lives. We also recognise the importance of family and caregivers, which is why we support and empower them in parallel to their loved-ones. We believe everyone should have access to quality, long-term neurorehabilitation and support.This project aims to strengthen neumind's digital strategy by developing and facilitating development of a personalisable digital rehabilitation course and therapeutic recommendations, in conjunction with key opinion leaders (KOLs), including world-leading academics, clinicians, and care providers. The outcomes of this project will form the therapeutic component of neumind's platform and offers a step-change in cost-effectiveness and quality of long-term support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
Next Generation Majorana Nanowire Hybrids
-
批准号:--
-
项目类别:--
-
资助金额:20万元
-
批准年份:2020
-
负责人:Panagiotis Kotetes
-
依托单位:
二次谐波非线性光学显微成像用于前列腺癌的诊断及药物疗效初探
-
批准号:30470495
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2004
-
负责人:邓小元
-
依托单位: